Salute e Benessere
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
"Klotho represents the next frontier in ," said , Chief Scientist at EWBG. "Our research aims to understand how Klotho affects aging and how we can use it to treat chronic diseases that have long been associated with aging."
The new initiative will focus on three primary research areas:
This research builds on existing collaborations at , where leading scientists focus on advancing Klotho-based therapies for regenerative health.
Klotho is gaining attention for its ability to regenerate tissues and reverse damage caused by age-related diseases. Unlike , which primarily enhances cellular metabolism and energy production, Klotho offers a broader range of therapeutic applications, including tissue regeneration, cognitive function improvement, and cardiovascular health.
As we age, Klotho levels naturally decline, leading to conditions such as cognitive decline, heart disease, and kidney failure. Research suggests that restoring Klotho levels can reverse the effects of oxidative stress, inflammation, and cellular senescence, offering new treatment possibilities for a range of age-related diseases.
, a leading expert in and , is spearheading this groundbreaking initiative at . His extensive experience in bio-regenerative medicine positions him as a key figure in exploring Klotho's potential to revolutionize the treatment of age-related diseases. Through , a subsidiary of EWBG, Professor Chan and his team are developing therapies that combine and to stimulate tissue regeneration in the , , and .
"By harnessing Klotho's regenerative properties, we hope to address chronic conditions that were previously untreatable," said . "Our ultimate goal is to improve quality of life and provide lasting solutions for those affected by aging-related diseases."
The future of looks promising, with and at the forefront of this innovative field. As more research is conducted, Klotho is expected to play a pivotal role in advancing , offering a new approach to treating aging and chronic diseases. The potential applications of Klotho are vast, from to and .
With strong research partnerships, significant funding, and ongoing clinical trials, Klotho is poised to become a cornerstone of , transforming how we approach aging and disease. leadership ensures that this promising protein will soon offer new hope to those seeking longer, healthier lives.
Photo - https://mma.prnewswire.com/media/2587407/Prof_Dr_Mike_Chan_talks_growing_importance_Klotho_anti_aging_medicine.jpg
Logo - https://mma.prnewswire.com/media/2362609/EW_COLOR_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/european-wellness-biomedical-group-announces-new-klotho-research-initiative-led-by-prof-mike-chan-302338980.html